Lantibiotics
Gallidermin | |||||||||
---|---|---|---|---|---|---|---|---|---|
Identifiers | |||||||||
Symbol | Gallidermin | ||||||||
TCDB | 1.C.20 | ||||||||
OPM superfamily | 161 | ||||||||
OPM protein | 1mqy | ||||||||
|
Lantibiotics are a class of poly
Lanthionine is composed of two alanine residues that are crosslinked on their β-carbon atoms by a thioether (monosulfide) linkage.
Lantibiotics are produced by a large number of
Lantibiotics are well studied because of the commercial use of these bacteria in the food industry for making dairy products such as cheese.
History
The name lantibiotics was introduced in 1988 as an abbreviation for "lanthionine-containing peptide antibiotics".
Classification
- Type A lantibiotics are long flexible molecules - e.g., mutacinII; subgroup AII includes mutacin I and III.
- Type B lantibiotics are globular - e.g., mersacidin.[3][4] actagardine, duramycin, and cinnamycin.[5]
Some contain 2 peptides, e.g. haloduracin.[6]
Examples
Lantibiotic | Type | # of residues |
# of thioether links |
Other links[clarification needed] |
refs |
---|---|---|---|---|---|
nisin subtilin |
A | 34 | 5 | 0 | |
gallidermin epidermin |
A | 21 | 3 | 1 | [2] |
mersacidin | B | 20 | 4 | [3] | |
actagardine | B | 19 | 4 | 0 | |
cinnamycin duramycin |
B | 19 | 3 | 1 | [5] |
sublancin 168 | ? | 37 | 1 | 2 | [7] |
plantaricin C | B | 27 | 4 | 0 |
(Sublancin may be an S-linked glycopeptide).[8]
Biosynthesis
They are synthesised with a leader polypeptide sequence that is removed only during the transport of the molecule out of the synthesising cell. They are synthesized by ribosomes, which distinguishes them from most natural antibiotics.[9] There are four known enzymes (lanthipeptide synthetases) responsible for producing lanthionine rings.[10][11]
Mechanism of action
Lantibiotics show substantial specificity for some components (e.g.,
Application
Food preservation
Lantibiotics are produced by Gram-positive bacteria and show strong antimicrobial action toward a wide range of other Gram-positive bacteria.
Clinical antibiotic
One type known as B lantibiotic
Databases
BACTIBASE is an open-access database for bacteriocins including lantibiotics.[17][18] LANTIBASE is a lantibiotic specific resource.[19]
References
- PMID 15700960.
- ^ PMID 3181159.
- ^ PMID 18947397.
- PMID 7793878.
- ^ PMID 12446685.
- PMID 18940665.
- S2CID 20144405.
- PMID 21196935.
- PMID 8647829.
- PMID 20351769.
- PMID 23071302.
- PMID 10882681.
- PMID 15638769. Archived from the original (PDF) on 2007-09-28. Retrieved 2007-06-01.)
{{cite journal}}
: CS1 maint: multiple names: authors list (link - ^ PMID 10584332.
- ^ "New antibiotic compound enters phase I clinical trial". Press Release. Wellcome Trust. 2011-11-03.
- ^ Parker S (2012-08-06). "Novacta Biosystems Limited completes Phase I study of NVB302 against C. difficile infection in healthy volunteers". Press Release. Celtic Pharma Holding. Archived from the original on 2013-09-01. Retrieved 2013-03-23.
- PMID 17941971.
- PMID 20105292.
- ^ "DBT Centre for Bioinformatics Presidency University, Kolkata". Archived from the original on 2013-08-15. Retrieved 2013-07-25.
Further reading
- Jack R, Bierbaum G, Heidrich C, Sahl HG (September 1995). "The genetics of lantibiotic biosynthesis". BioEssays. 17 (9): 793–802. S2CID 32393523.
- Sahl HG, Jack RW, Bierbaum G (June 1995). "Biosynthesis and biological activities of lantibiotics with unique post-translational modifications". Eur. J. Biochem. 230 (3): 827–53. PMID 7601145.
- Sahl HG, Bierbaum G (1998). "Lantibiotics: biosynthesis and biological activities of uniquely modified peptides from gram-positive bacteria". Annu. Rev. Microbiol. 52: 41–79. PMID 9891793.
- Stein T (May 2005). "Bacillus subtilis antibiotics: structures, syntheses and specific functions". Mol. Microbiol. 56 (4): 845–57. S2CID 20144405.
- Smith JL (2002). Structural and functional characterization of the lantibiotic mutacin (PDF) (Ph.D.). University of Florida.
External links
- Lantibase, a database of lantibiotics
- "Complete list of lantibiotics". BACTIBASE Database.